Newer antidepressants and panic disorder: a meta-analysis

@article{Andrisano2013NewerAA,
  title={Newer antidepressants and panic disorder: a meta-analysis},
  author={C. Andrisano and A. Chiesa and A. Serretti},
  journal={International Clinical Psychopharmacology},
  year={2013},
  volume={28},
  pages={33–45}
}
  • C. Andrisano, A. Chiesa, A. Serretti
  • Published 2013
  • Medicine
  • International Clinical Psychopharmacology
  • Selective serotonin reuptake inhibitors and venlafaxine are currently considered as first-line agents for patients with panic disorder (PD). However, a systematic comparison of newer antidepressants for the treatment of PD is lacking thus far. Eligible studies focusing on PD patients treated with newer antidepressants were entered in the Cochrane Collaboration Review Manager. Our primary outcome measure was the mean change in panic symptoms from the baseline to the endpoint in patients treated… CONTINUE READING
    43 Citations
    Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient
    • 3
    • Highly Influenced
    • PDF
    Antidepressants versus placebo for panic disorder in adults.
    • 16
    [Panic disorder: clinical phenomena and treatment options].
    • Y. P. Sivolap
    • Medicine
    • Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
    • 2017
    • 1
    A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder
    • 10
    A pharmacological approach to panic disorder during pregnancy
    • F. Uguz
    • Medicine
    • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
    • 2016
    • 2

    References

    SHOWING 1-10 OF 103 REFERENCES
    New treatment options for panic disorder: clinical trials from 2000 to 2010
    • 24
    Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
    • 107
    Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies
    • 27
    An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.
    • 133
    Mirtazapine versus fluoxetine in the treatment of panic disorder.
    • 64
    • Highly Influential
    • PDF
    Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
    • 14
    • Highly Influential
    Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    • 131
    • Highly Influential
    • PDF
    Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study.
    • 40
    • Highly Influential
    Combined Paroxetine and Clonazepam Treatment Strategies Compared to Paroxetine Monotherapy for Panic Disorder
    • 96
    • Highly Influential